GASTRIC OR GASTRO ESOPHAGEAL JUNCTION ADENOCARCINOMA

Clinical trials for GASTRIC OR GASTRO ESOPHAGEAL JUNCTION ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new GASTRIC OR GASTRO ESOPHAGEAL JUNCTION ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for GASTRIC OR GASTRO ESOPHAGEAL JUNCTION ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for tough stomach cancers: major trial tests promising drug

Disease control Recruiting now

This study is testing whether a new drug called BL-M07D1 works better than standard chemotherapy for people with advanced HER2-positive stomach or gastroesophageal cancer. It's for patients whose cancer has continued to grow despite their first round of treatment. The main goals …

Matched conditions: GASTRIC OR GASTRO ESOPHAGEAL JUNCTION ADENOCARCINOMA

Phase: PHASE3 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

GASTRIC OR GASTRO ESOPHAGEAL JUNCTION ADENOCARCINOMA

Get alerted when new GASTRIC OR GASTRO ESOPHAGEAL JUNCTION ADENOCARCINOMA trials appear

New hope for tough stomach cancers: major trial tests promising drug